Please log in to view this page
Username
Password
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
